TrialAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons2021

Every 2-month belatacept maintenance therapy in kidney transplant recipients greater than 1-year posttransplant: A randomized, noninferiority trial.

Idelberto R Badell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.